The ARTS-HF (minerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure) (NCT01807221) trial involved patients with HFrEF with worsening chronic features requiring hospitalization and treatment with intravenous diuretics [27]. This evidence concerns the gene NR3C2 and heart failure.